Browsing by Author Van Reyk, DM

Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
1-May-2015Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): Implications for foam cell formation in atherosclerosisIsmael, FO; Proudfoot, JM; Brown, BE; Van Reyk, DM; Croft, KD; Davies, MJ; Hawkins, CL
1-Feb-2014Supplementation with carnosine decreases plasma triglycerides andmodulates atherosclerotic plaque composition in diabetic apoE<sup>-/-</sup>miceBrown, BE; Kim, CHJ; Torpy, FR; Bursill, CA; McRobb, LS; Heather, AK; Davies, MJ; Van Reyk, DM
Jan-2013Is H+ the symbol for acid? Provision of learning support in foundation-level chemistry for Bachelor of Nursing students enrolled in bioscience subjectsVan Reyk, DM; Ang, K; Nelson, K; Kift, S; Field, R; Whelan, K; Smith, L; Clarke, J; Creag, T
24-Nov-2011Effect of exposure of human monocyte-derived macrophages to high, versus normal, glucose on subsequent lipid accumulation from glycated and acetylated low-density lipoproteinsMoheimani, F; Tan, JTM; Brown, BE; Heather, AK; Van Reyk, DM; Davies, MJ
1-Mar-2007Glycation of low-density lipoprotein results in the time-dependent accumulation of cholesteryl esters and apolipoprotein B-100 protein in primary human monocyte-derived macrophagesBrown, BE; Rashid, I; Van Reyk, DM; Davies, MJ
1-Dec-2006The Roles of protein glycation, glycoxidation, and advanced glycation end-product formation in diabetes-induced atherosclerosisRashid, I; Brown, BE; Van Reyk, DM; Davies, MJ
1-Apr-2006Hydrazine compounds inhibit glycation of low-density lipoproteins and prevent the in vitro formation of model foam cells from glycolaldehyde-modified low-density lipoproteinsBrown, BE; Mahroof, FM; Cook, NL; Van Reyk, DM; Davies, MJ